Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
PEEK brings a new quality to dental care for patients
The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing
Economic analysis of cost of Vall d’Hebron University Hospital Stroke Unit shows direct-to-angio stroke pathway can save more than USD 3,000 per patient
Survey of Unmet Needs in chronic myeloid leukemia (CML SUN) data signal need for amplified patient voice during treatment discussions that balance quality of life (QoL), efficacy, and tolerability goals across all lines of therapy
Subscribe To Our Newsletter & Stay Updated
